Article

Integration of clinical, pathological, radiological, and transcriptomic data improves the prediction of first-line immunotherapy outcome in metastatic non-small cell lung cancer

2024-06-28

Abstract excerpt

The survival of patients with metastatic non-small cell lung cancer (NSCLC) has been increasing with immunotherapy, yet efficient biomarkers are still needed to optimize patient care. In this study, we explored the benefits of multimodal approaches to predict immunotherapy outcome using multiple machine learning algorithms and integration strategies. We leveraged a novel multimodal cohort of 317 metastatic NSCLC p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8e4fc030-4800-552c-9085-8cdbbdd29a66
DOI: 10.1101/2024.06.27.24309583

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Integration of clinical, pathological, radiological, and transcriptomic data improves the prediction of first-line immunotherapy outcome in metastatic non-small cell lung cancerDOI 10.1101/2024.06.27.24309583Read

Multimodal prediction of tyrosine kinase inhibitors therapy outcomes in advanced EGFR-mutated NSCLC patients.Semantic proximity Read

I3LUNG: Clinical Validation of a Multimodal AI Tool to Support Immunotherapy Decisions in NSCLCSemantic proximity Read

Towards a Survival Risk Prediction Model for Metastatic NSCLC Patients on Durvalumab Using Whole-Lung CT RadiomicsSemantic proximity Read

Multi-Omics Integration for Identification of Prognostic Molecular Signatures for Survival Stratification in Lung CancerSemantic proximity Read

An integrated multimodal model for early prediction of high-risk recurrence phenotype indicative of poor disease-free survival in stage IA NSCLC: a multicenter study.Semantic proximity Read

The Brain-Lung Immunotherapy Prognostic (BLIP) Score: A Novel Robust Tool for Prognostication in Non-Small Cell Lung Cancer Patients with Brain MetastasesSemantic proximity Read

Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non-small cell lung cancer.Semantic proximity Read

Non-invasive decision support for NSCLC treatment using PET/CT radiomics.Semantic proximity Read

A Combination of Biomarkers Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer.Semantic proximity Read

Prediction of immunotherapy response using deep learning of PET/CT imagesSemantic proximity Read

Multimodal profiling for prediction of primary resistance to anti–PD-(L)1 therapy in advanced non-small-cell lung cancer: the prospective PIONeeR biomarkers studySemantic proximity Read

Identifying Patients with EGFR-Mutated Oligometastatic NSCLC Suitable for Third-Generation EGFR-TKI Combined with Thoracic Radiotherapy Using Nomograms Based on CT Radiomic and Clinicopathological Factors.Semantic proximity Read